Skip to main content
Have a personal or library account? Click to login
Hyperinsulinism-hyperammonemia syndrome in an infant with seizures Cover

Hyperinsulinism-hyperammonemia syndrome in an infant with seizures

Open Access
|Oct 2018

Figures & Tables

Table 1

Disorders associated with persistent hyperinsulinemic hypoglycemia of infancy.

General Characteristics
GeneMode of InheritanceLaboratory and Clinical Characteristics
PHHI due to K ATP channel mutationKir6.2: KCNJ11 gene; SUR: ABCC8 gene; imprinted regionDiffuse form: AR or AD; focal form: heterozygous paternal mutation, clonal loss of maternal 11p15.1↑ Glucose requirement (up to 30.0 mg/kg/ min.); during hypoglycemia: ↓ ketone bodies, ↓ FFA (serum), insulin incompletely suppressed, normal blood gases and lactate, n/↑ ammonium, IGFBP-1 (<120.0 mg/mL), normal glucagon response
Glucokinase activating mutationsGCK geneADHeterozygous: familial mild non progressive hyperglycemia, gestational diabetes; homozygous: neonatal diabetes
HI/HA syndromeGLUD1 geneADHyperammonemia (100.0-200.0 μmol/L), usually asymptomatic, may be prominent early but may disappear later in childhood; often leucine-sensitive
Exercise-induced hyperinsulinemic hypoglycemiaSLC16A1 promoter mutationsADChildren/adults with syncopal episodes after exercise
SCHAD deficiencyHADH geneARIntermittent unpredictable hypoglycemia with seizures; ↑ C4-OH-carnitine, ↑ 3-OH-glutarate (urine)
Beckwith- Wiedemann syndromeChromosomal imbalance 11p15e.g., paternal UPDHyperinsulinism (disappears in most patients within weeks); typical facial characteristics (macroglossia, ear creases, omphalocele, visceromegaly, hemihypertrophy)

[i] PHHI: persistent hyperinsulinemic hypoglycemia of infancy; AR: autosomal recessive; AD: autosomal dominant; ↑: elevated; ↓: low/decreased; FFA: free fatty acids; IGFBP-1: insulin-like growth factor-binding protein; HI/HA: hyperinsulinism-hyperammonemia; SCHAD: short-chain hydroxyacylCoA dehydrogenase; CA-OH-carnitine: 3-hydroxy-butyryl-carnitine; 3-OH-glutarate: 3-hydroxy-glutarate.

Figure 1

Patophysiological mechanism of hyperammoniemia in GDH deficiency.

M: mutation; GDH: glutamate dehydrogenase;

TCA: tricarboxylic acid; ATP: aden-osine triphosphate;

ADP: adenosine diphosphate; GTP: guanosine triphosphate; NAG: N-Acetylglutamate;

NAGS: N-Acetylglutamate synthase; CPS: carbamoyl-phosphate synthetase.

DOI: https://doi.org/10.2478/bjmg-2018-0014 | Journal eISSN: 2199-5761 (formerly 1311-0160) | Journal ISSN: 1311-0160
Language: English
Page range: 77 - 81
Published on: Oct 29, 2018
Published by: Macedonian Academy of Sciences and Arts
In partnership with: Paradigm Publishing Services

© 2018 A Strajnar, MZ Tansek, KT Podkrajsek, T Battelino, U Groselj, published by Macedonian Academy of Sciences and Arts
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.